High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the “SET” feature of high-grade serous carcinoma to the “STEM” feature

被引：0
|
作者：
Yuichiro Hatano
Maho Tamada
Nami Asano
Yoh Hayasaki
Hiroyuki Tomita
Ken-ichirou Morishige
Akira Hara
机构：
[1] Gifu University Graduate School of Medicine,Department of Tumor Pathology
[2] Gifu University Graduate School of Medicine,Department of Obstetrics and Gynecology
来源：
Diagnostic Pathology | / 14卷
关键词：
Ovary; High-grade serous carcinoma; SET feature; Mucinous differentiation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Concurrent High-Grade Serous Carcinoma with Mucinous Differentiation and Ectopic Complete Molar Pregnancy of the Fallopian Tube: A Case Report
    Ines, Flora Mae G. Sta.
    Al-Tarawneh, Bushra
    Marchese, Mary
    Jansen, Corinne
    De Paepe, Monique E.
    Sung, C. James
    Tatevian, Nina
    Quddus, M. Ruhul
    Lokich, Elizabeth
    Marketkar, Shivali
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2024, 54 (05): : 679 - 684
  • [42] Bilateral high-grade serous carcinoma of the fallopian tube with ovarian and uterine involvement - case report
    Popa, M.
    Enache, T.
    Olinca, M.
    Poteca, A.
    VIRCHOWS ARCHIV, 2021, 479 : S244 - S244
  • [43] Endometrial Serous Carcinoma with Shared Features of Ovarian High-Grade Serous Carcinoma: A Distinct Subset of Tumors?
    Strickland, Amanda
    Chen, Hao
    Wang, Yiying
    Niu, Shuang
    Lucas, Elena
    Rivera-Colon, Glorimar
    Gwin, Katja
    Carrick, Kelley
    Malpica, Anais
    Zheng, Wenxin
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1143 - 1143
  • [44] UTERINE SEROUS CARCINOMA IS MORE AGGRESSIVE THAN HIGH-GRADE SEROUS OVARIAN CARCINOMA: A RETROSPECTIVE STUDY
    Nagano, H.
    Tachibana, Y.
    Kawakami, M.
    Ueno, M.
    Morita, Y.
    Muraoka, M.
    Takagi, K.
    Fujibayashi, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1115 - 1115
  • [45] Endometrial Serous Carcinoma with Shared Features of Ovarian High-Grade Serous Carcinoma: A Distinct Subset of Tumors?
    Strickland, Amanda
    Chen, Hao
    Wang, Yiying
    Niu, Shuang
    Lucas, Elena
    Rivera-Colon, Glorimar
    Gwin, Katja
    Carrick, Kelley
    Malpica, Anais
    Zheng, Wenxin
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1143 - 1143
  • [46] BRCA gene testing in women with high-grade serous ovarian carcinoma
    Kansu, Bengi
    Gardner, Jennifer
    Price-Tate, Rachel
    Murch, Oliver
    Murray, Alex
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 41 (06) : 962 - 965
  • [47] Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma
    Santillan, A.
    Kim, Y. W.
    Zahurak, M. L.
    Gardner, G. J.
    Giuntoli, R. L., II
    Shih, I. M.
    Bristow, R. E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (03) : 601 - 606
  • [48] Prognostic relevance of gene signatures in high-grade serous ovarian carcinoma
    Konecny, Gottfried E.
    Wang, Chen
    Winterhoff, Boris
    Dering, Judy
    Ginther, Charles
    Chen, Hsiao-Wang
    Hamidi, Habib
    Podratz, Karl C.
    Cliby, William
    Dowdy, Sean Christopher
    Haluska, Paul
    Hartmann, Lynn C.
    Kalli, Kimberly
    Goode, Ellen L.
    Slamon, Dennis J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] Cellular plasticity and migratory modalities in high-grade serous ovarian carcinoma
    Bapat, Sharmila A.
    Varankar, Sagar
    CANCER RESEARCH, 2019, 79 (13)
  • [50] Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
    Arend, Rebecca C.
    Londono, Angelina I.
    Montgomery, Allison M.
    Smith, Haller J.
    Dobbin, Zachary C.
    Katre, Ashwini A.
    Martinez, Alba
    Yang, Eddy S.
    Alvarez, Ronald D.
    Huh, Warner K.
    Bevis, Kerri S.
    Straughn, J. Michael, Jr.
    Estes, Jacob M.
    Novak, Lea
    Crossman, David K.
    Cooper, Sara J.
    Landen, Charles N.
    Leath, Charles A., III
    MOLECULAR CANCER RESEARCH, 2018, 16 (05) : 813 - 824
12345